Micol Massimiani
Overview
Explore the profile of Micol Massimiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacconi V, Massimiani M, Antonello G, Gasco P, Bernardini R, Ferrari C, et al.
Front Toxicol
. 2025 Jan;
6():1508598.
PMID: 39839550
Solid lipid nanoparticles (SLNs) have gained interest as drug delivery carriers due to their efficient cellular internalization and increased therapeutic effect of the loaded drug, with minimal side effects. Although...
2.
Salvi S, Fruci S, Lacconi V, Totaro Aprile F, Rullo R, Stuhlmann H, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200393
The primary intervention for pre-eclampsia (PE) remains iatrogenic delivery, which can be very preterm and not optimal for the fetus. Although many efforts have been made to prevent and manage...
3.
Lacconi V, Massimiani M, Carriero I, Bianco C, Ticconi C, Pavone V, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474081
Evaluation of the optimal number of embryos, their quality, and the precise timing for transfer are critical determinants in reproductive success, although still remaining one of the main challenges in...
4.
Lacconi V, Massimiani M, Paglione L, Messina A, Battistini B, De Filippis P, et al.
Toxicol Appl Pharmacol
. 2022 May;
446:116056.
PMID: 35537546
The study of developmental effect of xenobiotics in humans is limited and often relies on epidemiological data. Whether and to which extent potentially toxic compounds may cross the placental barrier,...
5.
Manna C, Lacconi V, Rizzo G, De Lorenzo A, Massimiani M
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35054845
Obstetric and newborn outcomes of assisted reproductive technology (ART) pregnancies are associated with significative prevalence of maternal and neonatal adverse health conditions, such as cardiovascular and metabolic diseases. These data...
6.
Massimiani M, Salvi S, Tiralongo G, Moresi S, Stuhlmann H, Valensise H, et al.
Sci Rep
. 2021 Sep;
11(1):17919.
PMID: 34504270
Isolated intrauterine growth restriction (IUGR) and preeclampsia (PE) share common placental pathogenesis. Differently from IUGR, PE is a systemic disorder which may also affect liver and brain. Early diagnosis of...
7.
Camaioni A, Massimiani M, Lacconi V, Magrini A, Salustri A, Sotiriou G, et al.
Part Fibre Toxicol
. 2021 Sep;
18(1):33.
PMID: 34479598
Background: Metal oxide nanoparticles (NPs) are increasingly used in many industrial and biomedical applications, hence their impact on occupational and public health has become a concern. In recent years, interest...
8.
Dal Lago A, Galanti F, Miriello D, Marcoccia A, Massimiani M, Campagnolo L, et al.
J Clin Med
. 2021 Jun;
10(10).
PMID: 34068288
Impaired thyroid hormone availability during early pregnancy is associated with recurrent miscarriage (RM) and adverse pregnancy outcomes. The main cause of thyroid dysfunction is thyroid-related autoimmunity (TAI), characterized by a...
9.
Massimiani M, Tiralongo G, Salvi S, Fruci S, Lacconi V, La Civita F, et al.
Transl Res
. 2020 Aug;
228:28-41.
PMID: 32784003
Intrauterine growth restriction (IUGR) is a pathological condition of pregnancy with high perinatal mortality and morbidity, characterized by inadequate fetal growth associated to altered maternal hemodynamics with impaired uteroplacental blood...
10.
Massimiani M, Lacconi V, La Civita F, Ticconi C, Rago R, Campagnolo L
Int J Mol Sci
. 2019 Dec;
21(1).
PMID: 31861484
Implantation of the embryo into the uterine endometrium is one of the most finely-regulated processes that leads to the establishment of a successful pregnancy. A plethora of factors are released...